A frightening mix of cruel and superficial.
November 2, 2016
One means of judging the competing presidential candidates is to examine their actual policy prescriptions for dealing with serious issues facing the country. When it comes to drug policy, the contrasts between Hillary Clinton and Donald Trump couldn’t be more telling.
The country is in the midst of what can fairly be called an opioid crisis, with the CDC reporting 78 Americans dying every day from heroin and prescription opioid overdoses. Both candidates have addressed the problem on the campaign trail, but as is the case in so many other policy areas, one candidate has detailed proposals, while the other offers demagogic sloganeering.
Hillary Clinton has offered a detailed $10 billion plan to deal with what she calls the “quiet epidemic” of opioid addiction. Donald Trump’s plan consists largely of “build the wall.”
That was the centerpiece of his October 15 speech in New Hampshire where he offered his clearest drug policy prescriptions yet (though it was overshadowed by his weird demand that Hillary Clinton undergo a drug test). To be fair, since then, Trump has also called for expanding law enforcement and treatment programs, but he has offered no specifics or cost estimates.
And the centerpiece of his approach remains interdiction, which dovetails nicely with his nativist immigration positions.
“A Trump administration will secure and defend our borders,” he said in that speech. “A wall will not only keep out dangerous cartels and criminals, but it will also keep out the drugs and heroin poisoning our youth.”
Trump did not address the failure of 40 years of ever-increasing border security and interdiction policies to stop the flow of drugs up until now, nor did he explain what would prevent a 50-foot wall from being met with a 51-foot ladder.
Trump’s drug policy also takes aim at a favorite target of conservatives: so-called sanctuary cities, where local officials refuse to cooperate in harsh federal deportation policies.
“We are also going to put an end to sanctuary cities, which refuse to turn over illegal immigrant drug traffickers for deportation,” he said. “We will dismantle the illegal immigrant cartels and violent gangs, and we will send them swiftly out of our country.”
In contrast, Clinton’s detailed proposal calls for increased federal spending for prevention, treatment and recovery, first responders, prescribers, and criminal justice reform. The Clinton plan would send $7.5 billion to the states over 10 years, matching every dollar they spend on such programs with four federal dollars. Another $2.5 billion would be designated for the federal Substance Abuse Prevention and Treatment Block Grant program.
While Trump advocates increased border and law enforcement, including a return to now widely discredited mandatory minimum sentencing for drug offenders, Clinton does not include funding for drug enforcement and interdiction efforts in her proposal. Such funding would presumably come through normal appropriations channels.
Instead of a criminal justice crackdown, Clinton vows that her attorney general will issue guidance to the states urging them to emphasize treatment over incarceration for low-level drug offenders. She also supports alternatives to incarceration such as drug courts (as does Trump). But unlike Trump, Clinton makes no call for increased penalties for drug offenders.
Trump provides lip service to prevention, treatment and recovery, but his rhetorical emphasis illuminates his drug policy priorities: more walls, more law enforcement, more drug war prisoners.
There is one area of drug policy where both candidates are largely in agreement, and that is marijuana policy. Both Clinton and Trump have embraced medical marijuana, both say they are inclined to let the states experiment with legalization, but neither has called for marijuana legalization or the repeal of federal pot prohibition.
If Clinton’s drug policies can be said to be a continuation of Obama’s, Trump’s drug policies are more similar to a return to Nixon’s.
Phillip Smith is editor of the AlterNet Drug Reporter and author of the Drug War Chronicle.